High-dose, frequently administered interferon beta therapy for relapsing-remitting multiple sclerosis must be maintained over the long term: the interferon beta dose-reduction study
(Q47234278)
scientific article published in July 2004
scientific article published in July 2004
Language:
other details
| description | scientific article published in July 2004 |
External Links
| (P356) |
10.1016/J.JNS.2004.03.023
|
| (P698) |
15240190
|